Speaker illustration

undefined undefined undefined

The effect of iron deficiency treatment with intravenous ferric carboxymaltose on the arrhythmic burden of patients with HFrEF and cardiac implantable electronic devices

Event: ESC Congress 2023

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: HFrEF pathophysiology

Thumbnail

Intravenous iron therapy and arrhythmic burden in heart failure with reduced ejection fraction and iron deficiency

Event: Heart Failure 2021

Topic: Treatment

Session: ePoster session

Thumbnail

ESC 365 is supported by